HUMA

insider transactions

Humacyte, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 11, 26

Susan Richards Windham-Bannister

Director

$0

80.0K sh

Own New
Grant·A
Jun 11, 26

Max N. Wallace

Director

$0

80.0K sh

Own New
Grant·A
Jun 11, 26

Laura E Niklason KEY

President, CEO and Director

$0

80.0K sh

Own New
Grant·A
Jun 11, 26

Kathleen Sebelius

Director

$0

80.0K sh

Own New
Grant·A
Jun 11, 26

Keith Anthony Jones

Director

$0

80.0K sh

Own New
Grant·A
Jun 11, 26

Diane Seimetz

Director

$0

80.0K sh

Own New
Grant·A
Jun 11, 26

Charles Bruce Green

Director

$0

80.0K sh

Own New
Grant·A
Jun 11, 26

Brady W Dougan

Director

$0

0 sh
Grant·A
Jun 11, 26

Michael T. Constantino

Director

$0

80.0K sh

Own New
Grant·A
Jun 11, 26

Emery N. Brown

Director

$0

80.0K sh

Own New
Grant·A
Jun 11, 26

John Philip Bamforth

Director

$0

80.0K sh

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 11, 2026	Susan Richards Windham-Bannister	Director	Grant A	80.0K	New	—	$0
Jun 11, 2026	Max N. Wallace	Director	Grant A	80.0K	New	—	$0
Jun 11, 2026	Laura E Niklason KEY	President, CEO and Director	Grant A	80.0K	New	—	$0
Jun 11, 2026	Kathleen Sebelius	Director	Grant A	80.0K	New	—	$0
Jun 11, 2026	Keith Anthony Jones	Director	Grant A	80.0K	New	—	$0
Jun 11, 2026	Diane Seimetz	Director	Grant A	80.0K	New	—	$0
Jun 11, 2026	Charles Bruce Green	Director	Grant A	80.0K	New	—	$0
Jun 11, 2026	Brady W Dougan	Director	Grant A	0	—	—	$0
Jun 11, 2026	Michael T. Constantino	Director	Grant A	80.0K	New	—	$0
Jun 11, 2026	Emery N. Brown	Director	Grant A	80.0K	New	—	$0
Jun 11, 2026	John Philip Bamforth	Director	Grant A	80.0K	New	—	$0

About HUMA insider trading

This page tracks insider transactions for Humacyte, Inc. (HUMA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.